Search Results 841-850 of 24346 for In situ

  1. S0820, Adenoma and Second Primary Prevention Trial - Mayo Clinic

    There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. ... Will not participate in ... situ cervical cancer ...

  2. Minimally invasive surgery - Doctors & Departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. ... situ, Ductal ...

  3. Minimally invasive surgery - Doctors & Departments - Mayo Clinic

    Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. ... situ, Ductal ...

  4. Soft tissue sarcoma - Doctors and departments - Mayo Clinic

    ... situ cold perfusion, Robotic splenectomy ... Mayo Clinic in Rochester, Minnesota, Mayo Clinic in ... in care. So in many ways, it's a cycle. It can start ...

  5. A Study of the Safety and Effectiveness of TH-302 Combined with Gemcitabine and Compared with Gemcitabine Alone for Previously Untreated Patients with Pancreatic Adenocarcinoma - Mayo Clinic

    There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. ... situ cancer, or other cancer from which the ...

  6. Medical Research & Education - Mayo Clinic News Network

    Mayo Clinic Q&A podcast: COVID-19 trials pause over safety concerns featured image · Aging · Mayo Clinic Q&A podcast: Clinical trial for ductal carcinoma in situ ...

  7. Clinical trials - Oncology (Medical)

    ... in treating patients with HER2 expressing ductal carcinoma in situ. H2NVAC is a vaccine designed to stimulate specialized white blood cells in hopes of ...

  8. Breast cancer - Doctors and departments - Mayo Clinic

    ... situ, Recurrent breast cancer, Inflammatory ... in situ, Atypical hyperplasia of the breast, HER2 ... Mayo Clinic in Rochester, Minnesota, Mayo Clinic in ...

  9. Autologous, MUC1-Activated T Cells Expanded From Peripheral Blood in Patients With Relapsed and Resistant Ovarian Cancer - Mayo Clinic

    EXCEPTIONS: Non-melanotic skin cancer or carcinoma-in-situ of the cervix. NOTE: If there is a history of other malignancy, the patient must not be receiving ...

  10. A Study to Evaluate the Safety and Efficacy of ABT-494 for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    History of any malignancy, except for successfully treated nonmelanoma skin cancer (NMSC) or localized carcinoma in situ of the cervix. History of ...